India · Delayed Price · Currency is INR Nectar Lifesciences Statistics
Total Valuation
NSE:NECLIFE has a market cap or net worth of INR 2.84 billion. The enterprise value is 7.36 billion.
| Market Cap | 2.84B |
| Enterprise Value | 7.36B |
Important Dates
The next estimated earnings date is Friday, January 23, 2026.
| Earnings Date | Jan 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:NECLIFE has 194.26 million shares outstanding. The number of shares has decreased by -1.69% in one year.
| Current Share Class | 194.26M |
| Shares Outstanding | 194.26M |
| Shares Change (YoY) | -1.69% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 56.26% |
| Owned by Institutions (%) | 5.89% |
| Float | 82.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.07 |
| EV / Sales | 0.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.84 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -7.73% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 14.18% |
| Revenue Per Employee | 9.35M |
| Profits Per Employee | -1.99M |
| Employee Count | 1,786 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -591.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.77% in the last 52 weeks. The beta is 0.55, so NSE:NECLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -62.77% |
| 50-Day Moving Average | 17.94 |
| 200-Day Moving Average | 18.45 |
| Relative Strength Index (RSI) | 32.37 |
| Average Volume (20 Days) | 493,637 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NECLIFE had revenue of INR 16.70 billion and -3.55 billion in losses. Loss per share was -15.86.
| Revenue | 16.70B |
| Gross Profit | 2.82B |
| Operating Income | -904.27M |
| Pretax Income | -1.06B |
| Net Income | -3.55B |
| EBITDA | -267.85M |
| EBIT | -904.27M |
| Loss Per Share | -15.86 |
Balance Sheet
The company has 64.60 million in cash and 4.59 billion in debt, with a net cash position of -4.52 billion or -23.29 per share.
| Cash & Cash Equivalents | 64.60M |
| Total Debt | 4.59B |
| Net Cash | -4.52B |
| Net Cash Per Share | -23.29 |
| Equity (Book Value) | 7.17B |
| Book Value Per Share | 31.97 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 16.88%, with operating and profit margins of -5.41% and -21.26%.
| Gross Margin | 16.88% |
| Operating Margin | -5.41% |
| Pretax Margin | -6.32% |
| Profit Margin | -21.26% |
| EBITDA Margin | -1.60% |
| EBIT Margin | -5.41% |
| FCF Margin | n/a |
Dividends & Yields
NSE:NECLIFE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.69% |
| Shareholder Yield | 1.69% |
| Earnings Yield | -125.02% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 12, 2008. It was a forward split with a ratio of 10.
| Last Split Date | Nov 12, 2008 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |